EN CN


Featured Services

Return

Spectral Shift Services

BIOPHYSICAL ASSAY PLATFORM
Spectral Shift Assay

Spectral Shift is a technique used to study molecular interactions. During detection, one molecule is labeled with a fluorophore. When the fluorescently labeled molecule interacts with a ligand, changes in the chemical environment around the fluorophore cause a shift in its fluorescence emission spectrum. These spectral changes are monitored to determine the occurrence and extent of binding between the molecule and the ligand.

As an emerging technique for detecting molecular interactions, Spectral Shift technology provides high-quality data, sensitively identifies true binding molecules, and delivers reliable sample detection with limited assay optimization.

Spectral Shift assay principle and Dianthus instrument

Nanotemper Dianthus and Spectral Shift assay principle. When a target molecule interacts with a ligand, the chemical environment around the fluorophore changes, causing a subtle shift in emission wavelength under isothermal conditions. The fluorescence ratio is determined by simultaneously recording emission at two pre-selected wavelengths, enabling sensitive detection of binding events.

PLATFORM FEATURES
Key capabilities
01 · In-House Proteins
Highly active, in-house produced proteins support a broad range of biophysical assay applications.
02 · Wide Range of Applications
Suitable for small-molecule and fragment screening, affinity analysis, hit validation, lead optimization, SAR studies, binary and ternary degrader complexes, and protein–protein interactions.
03 · High Sensitivity
The Dianthus system detects sub-nanometer spectral shifts near maximum emission wavelengths for precise affinity measurements.
04 · High Throughput
384-well microplate detection can be completed in approximately 33 minutes, with Kd determination in approximately 1 minute per sample.
05 · High Flexibility
A solution-phase, microplate-based, microfluidic-free affinity screening platform that is independent of molecular-weight variation.
ASSAY WORKFLOW
Spectral Shift workflow
01  Fluorescently label the target molecule.
02  Mix the labeled molecule with a gradient dilution of the ligand.
03  Detect fluorescence emission at 650 nm and 670 nm using the instrument.
04  Fit the fluorescence intensity ratio against ligand concentration to calculate the affinity constant (Kd).
REPRESENTATIVE DATA
Spectral Shift binding analysis

Spectral Shift binding affinity assessment of MZ1 to BRD2 BD2

Binding affinity assessment of MZ1, a PROTAC, to BRD2 (BD2) using Spectral Shift technology. The dose–response curve shows the binding interaction between MZ1 and BRD2, yielding a dissociation constant (Kd) of 8.1 nM. Key metrics include an S/B ratio of 0.163, a signal-to-noise ratio of 44.7, and a saturation level of 99.6%, demonstrating a high-affinity binding interaction. BRD2 recognizes acetylated lysines on histones and participates in chromatin remodeling, transcriptional regulation, proliferation, and apoptosis.


Contact Us

We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.

We are a CRO service organization, not a hospital




Get a quote

Go top